AR111482A1 - VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS - Google Patents

VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS

Info

Publication number
AR111482A1
AR111482A1 ARP180101004A ARP180101004A AR111482A1 AR 111482 A1 AR111482 A1 AR 111482A1 AR P180101004 A ARP180101004 A AR P180101004A AR P180101004 A ARP180101004 A AR P180101004A AR 111482 A1 AR111482 A1 AR 111482A1
Authority
AR
Argentina
Prior art keywords
product
chitosan
mastitis
treatment
sol
Prior art date
Application number
ARP180101004A
Other languages
Spanish (es)
Inventor
Oscar Suarez
Alexandre Therrien
Sumitra Rajagopalan
Jeffrey Ellis Price
Todd Foster
John Mark Heimlich
Derek James Sheehan
Christina Lee Brown
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of AR111482A1 publication Critical patent/AR111482A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicación 1: Un producto para prevenir o tratar un trastorno mamario en un animal hembra no humano, caracterizado porque comprende una cantidad efectiva de un compuesto mixto de polímero de sol-gel que comprende quitosano, un polímero hidrófilo separado del quitosano, un agente gelificante y un medio adecuado, y el producto que comprende adicionalmente un polisiloxano. Reivindicación 13: El producto de conformidad con la reivindicación 1, caracterizado porque el compuesto mixto de polímero de sol-gel comprende además uno o más agentes antimicrobianos. Reivindicación 14: El producto de conformidad con la reivindicación 13, caracterizado porque el agente antimicrobiano se selecciona del grupo que consiste de un macrólido, una cefalosporina, un antibiótico lincosaminida, una fluoroquinolona, una tetraciclina, una penicilina, una espectinomicina, una sulfonamida, un cloranfenicol, un análogo sintético fluorado de tiamfenicol y una mezcla de los mismos.Claim 1: A product for preventing or treating a breast disorder in a non-human female animal, characterized in that it comprises an effective amount of a mixed compound of sol-gel polymer comprising chitosan, a hydrophilic polymer separated from chitosan, a gelling agent and a suitable medium, and the product additionally comprising a polysiloxane. Claim 13: The product according to claim 1, characterized in that the mixed sol-gel polymer compound further comprises one or more antimicrobial agents. Claim 14: The product according to claim 13, characterized in that the antimicrobial agent is selected from the group consisting of a macrolide, a cephalosporin, an antibiotic lincosaminide, a fluoroquinolone, a tetracycline, a penicillin, a spectinomycin, a sulfonamide, a chloramphenicol, a fluorinated synthetic analogue of thiamphenicol and a mixture thereof.

ARP180101004A 2017-04-20 2018-04-19 VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS AR111482A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762487601P 2017-04-20 2017-04-20

Publications (1)

Publication Number Publication Date
AR111482A1 true AR111482A1 (en) 2019-07-17

Family

ID=67439471

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101004A AR111482A1 (en) 2017-04-20 2018-04-19 VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS

Country Status (1)

Country Link
AR (1) AR111482A1 (en)

Similar Documents

Publication Publication Date Title
DOP2019000110A (en) 1,2,4–2,4,5–TRI-SUBSTITUTED TRIAZOLONES
CL2018001549A1 (en) Hmos Mix
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
UY37606A (en) 2-HETEROARIL-3-OXO-2,3-DIHIDROPIRIDAZIN-4-CARBOXAMIDS
SA517381998B1 (en) Composition for a Wound Dressing
UY37687A (en) VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS
UY36973A (en) SOL-GEL POLYMERIC COMPOUNDS AND THEIR USES
AU2016278853A8 (en) Petrolatum-based compositions comprising cationic biocides
BR112016013684A2 (en) AQUEOUS OR HYDROCOLOID SOLUTION, METHOD FOR INCREASE THE VISCOSITY OF A COMPOSITION AND METHOD FOR TREATMENT OF A MATERIAL
MX2020012041A (en) Pharmaceutical formulation.
UY37460A (en) 1,2,4-TRIAZOLONS WITH ANALATION IN 4 AND 5
PE20171238A1 (en) STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR NUCLEIC ACIDS ADMINISTRATION
CO2020012060A2 (en) Arginase inhibitors
ECSP20081995A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASEMIAS
BR112017006406A2 (en) compositions and methods for the treatment and prophylaxis of surgical site infections
CU20200008A7 (en) SUBSTITUTE DIHYDROOXADIAZINONE COMPOUNDS USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES, METHODS FOR PREPARING SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201991501A1 (en) ANTI-MICROBIAL COMPOSITION CONTAINING OLIGODYNAMIC METAL
WO2019169333A8 (en) Afibrotic compounds, devices, and uses thereof
CO2021005451A2 (en) Antimicrobial Gas Release Agents and Systems and Methods for Using Them
CL2018001590A1 (en) Pharmaceutical compositions comprising some phenylaminopyrimidine derivative.
ES2895910T3 (en) Multiphase compositions
BR112018074823A2 (en) polyalkylene oxide asparaginase formulations and methods of manufacture and use thereof
AU2017266410A1 (en) Palpable marker composition
MX2021001921A (en) Feed compositions and feed additive compositions for aquaculture species.
AR111482A1 (en) VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS